Does COVID-19 Cause Intestinal Angina?

Based on an article titled “Bowel ischemia in COVID-19: A systematic review”

Original written by: Patel et al., 2021

https://onlinelibrary.wiley.com/doi/10.1111/ijcp.14930

By: Murielle Nsiela 

Intestinal angina is abdominal pain due to reduced blood flow to the intestines. This occurs as a result of a blockage in the superior mesenteric artery, found in the intestines, due to the build-up of fat or a blood clot. ; tThis issue can progress to sepsis or potentially death. It is said that people assigned female at birth (AFAB) are three times more likely to develop intestinal angina than people assigned male at birth (AMAB).1 

The disorder’s symptoms include having abdominal cramps approximately 30 minutes after a meal, with the pain lasting for one to three hours. In addition to this, unintentional weight loss or anorexia, bloating, nausea, and diarrhoea are common symptoms.2 

Several risk factors are associated with intestinal angina, including age: about 80-85% of individuals diagnosed with intestinal angina are aged 60 years and above. Furthermore, smoking statistics show that 75-80% of individuals diagnosed with abdominal angina are smokers.3 In addition, hypertension, heart failure and blood-clotting factors play a role in developing intestinal angina.2 

Furthermore, both type 1 and 2 diabetes, have been seen in patients diagnosed with the disorder; about 82% of individuals have diabetes upon diagnosis.1 Despite these risk factors, there have been speculations about whether COVID-19 could potentially cause intestinal angina, as there have been reports of gastrointestinal complications in patients with COVID-19 in the past two years. Therefore, a study by Patel et al. carried out a systematic review to gain a better understanding of COVID-19 induced intestinal angina.4 

COVID-19 (also known as SARS-CoV-2) is a type of virus that spreads through air droplets which can cause mild symptoms from loss of taste and smell, to severe symptoms such as respiratory distress syndrome.5 

It has been suggested that the SARS-CoV-2 produces an environment in the body where blood clots are easily developed, leading to blood clots in the arteries and veins.6 As a result, this affects the cardiovascular, nervous, and gastrointestinal systems. Potential effects of blood clots caused by COVID-19 include intestinal angina and stroke.7 

The study showed a strong relationship between the severity of COVID-19 and gastrointestinal symptoms. It was proved that 40% of coronavirus-positive patients had adverse gastrointestinal symptoms, and abdominal pain was linked to a 2.8 fold increased chance of developing severe COVID-19 symptoms.8  

As some COVID-19 patients are asymptomatic, it is easy to miss some of these cases; therefore, further investigations are required, such as conducting stool PCR.9,10 With the growing number of studies on coronavirus, it was found that 48.5% of COVID-19 patients presented with symptoms of anorexia, diarrhoea, abdominal pain and vomiting.110 

As this is an evolving topic, there are no specific management guidelines for COVID-19 related intestinal angina. However, some drugs can be administered to prevent the disease from occurring. In addition, screening with X-ray (CT) imaging of the abdomen can help early diagnosis of intestinal angina.112 In addition, there are surgical options available for patients.4 

In conclusion, intestinal angina is a complication of COVID-19, which requires early diagnosis for better outcomes. However, more studies are required for better management. 

References 

  1. Tyson R. Diagnosis and treatment of abdominal angina. The Nurse Practitioner. 2010;35(11):16-22. https://journals.lww.com/tnpj/Fulltext/2010/11000/Diagnosis_and_treatment_of_abdominal_angina.7.aspx
  2. Intestinal ischemia - Symptoms and causes [Internet]. Mayo Clinic. 2022 [cited 13 March 2022]. Available from: https://www.mayoclinic.org/diseases-conditions/intestinal-ischemia/symptoms-causes/syc-20373946
  3. Abdominal Angina: Practice Essentials, Pathophysiology and Etiology, Epidemiology [Internet]. Emedicine.medscape.com. 2022 [cited 13 March 2022]. Available from: https://emedicine.medscape.com/article/188618-overview
  4. Patel S, Parikh C, Verma D, Sundararajan R, Agrawal U, Bheemisetty N et al. Bowel ischemia in COVID‐19: A systematic review. International Journal of Clinical Practice. 2021;75(12). https://onlinelibrary.wiley.com/doi/10.1111/ijcp.14930
  5. Waleed MS, Sadiq W, Azmat M. Understanding the mosaic of COVID-19: a review of the ongoing crisis. Cureus. 2020; 12(3):e7366.
  6. https://www.cureus.com/articles/29367-understanding-the-mosaic-of-covid-19
  7. Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020; 19: 101- 115. https://www.sciencedirect.com/science/article/pii/S0049384820302711
  8. Kaur S, Bansal R, Kollimuttathuillam S, et al. The looming storm: blood and cytokines in COVID-19. Blood Rev. 2021; 46:100743. https://pubmed.ncbi.nlm.nih.gov/32829962/
  9. Zeng W, Qi K, Ye M, et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019. Eur J Gastroenterol Hepatol. 2021 Feb 25.  https://journals.lww.com/eurojgh/Fulltext/2022/02000/Gastrointestinal_symptoms_are_associated_with.8.aspx
  10. PCR DNA Parasite Stool Test - Testing Guide for Patients [Internet]. Parasites.org n.d. [cited 13 March 2022]. Available from: https://www.parasites.org/pcr-parasite-test-dna/
  11. Tang N. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5): 1094- 1099.  https://onlinelibrary.wiley.com/doi/10.1111/jth.14817
  12. Pan L, Mu MI, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115(5): 766- 773. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172492/
  13. Tang A, Tong ZD, Wang HL, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020; 26: 1337- 1339.  https://pubmed.ncbi.nlm.nih.gov/32150527/
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Murielle Nsiela

MSc Graduate in Medical Engineering - Bachelor's degree, Pharmaceutical Science, Keele University, Staffordshire UK

MSc in Medical Engineering Design, Keele University Modules included: Advanced engineering applications, Engineering for medical applications report, Bioreactors and Growth environment, Creative engineering design, Experimental research methodology and research projects



BSc (Hons) Pharmaceutical Science, Technology and Business, Keele University Modules included: Core topics in pharmaceutical science, Laboratory studies - tabletting and liposomes report, applied Pharmaceutical Science 2, Pharmaceutical research project

Leave a Reply

Your email address will not be published. Required fields are marked *

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818